Skip to main content

ADVERTISEMENT

Drug-eluting stent

Comparison Between Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Bioresorbable Vascular Scaffolds
06/01/2021

Andrew Kei-Yan Ng, MBBS1;  Pauline Yeung Ng, MBBS2,3;  Chung-Wah Siu, MD4;  Man-Hong Jim, MD1

Andrew Kei-Yan Ng, MBBS1;  Pauline Ye...
The study objective is to compare the major adverse cardiovascular event rates after implantation of BVS, first-generation DES, and BMS.
The study objective is to compare the major adverse cardiovascular event rates after implantation of BVS, first-generation DES, and BMS.
The study objective is to...
06/01/2021
Journal of Invasive Cardiology
03/28/2019

Francesco Burzotta, MD, PhD1*;  Osama Shoeib, MD, PhD2*;  Cristina Aurigemma, MD, PhD1;   Italo Porto, MD, PhD1;  Antonio Maria Leone, MD, PhD1;  Giampaolo Niccoli, MD, PhD1;   Lorenzo Genuardi, MD1;  Carlo Trani, MD1;  Filippo Crea, MD1

Francesco Burzotta, MD, PhD1*;  Osama...
This study was designed to help assess the impact of lesion predilation with kissing inflation using under-sized balloons (pre-kissing) on the procedural outcome of percutaneous coronary intervention (PCI) on complex bifurcation lesions...
This study was designed to help assess the impact of lesion predilation with kissing inflation using under-sized balloons (pre-kissing) on the procedural outcome of percutaneous coronary intervention (PCI) on complex bifurcation lesions...
This study was designed to help...
03/28/2019
Journal of Invasive Cardiology
01/14/2019
This study assesses very long-term performance and outcomes of the everolimus-eluting stent in a real-world population.
This study assesses very long-term performance and outcomes of the everolimus-eluting stent in a real-world population.
This study assesses very...
01/14/2019
Journal of Invasive Cardiology
Original Contribution
11/11/2018

Marc Laine, MD1;  Thibaut Dabry, MD1;  Nicolas Combaret, MD2;  Pascal Motreff, MD, PhD2;  Etienne Puymirat, MD, PhD3;  Franck Paganelli, MD, PhD1;  Franck Thuny, MD, PhD1;  Jennifer Cautela, MD1;  Michael Peyrol, MD1;  Julien Mancini, MD4;  Gilles Lemesle, MD, PhD5;  Laurent Bonello, MD, PhD1

Marc Laine, MD1;  Thibaut Dabry, MD1;...
The aim of the present study is to evaluate very early strut coverage with OCT of the Synergy stent (Boston Scientific) at 1 month in non-ST segment elevation acute coronary syndrome patients.
The aim of the present study is to evaluate very early strut coverage with OCT of the Synergy stent (Boston Scientific) at 1 month in non-ST segment elevation acute coronary syndrome patients.
The aim of the present study is...
11/11/2018
Journal of Invasive Cardiology
Original Contribution
09/30/2018

Haekyung Jeon-Slaughter, PhD1,2;  Houman Khalili, MD1,2;  Shirling Tsai, MD1,2;  Ehrin J. Armstrong, MD3;  Nicolas W. Shammas, MD4;  Omar Jawaid, MD3;  Hua Lu, MD1,2;  Tayo Addo, MD1;  Osvaldo Gigliotti, MD5;  Mazen Abu-Fadel, MD6;  Subhash Banerjee, MD1,2

Haekyung Jeon-Slaughter, PhD1,2;  Hou...
This study compared clinically driven target-lesion revascularization, target-vessel revascularization, and target-limb revascularization outcomes at 1 year between drug-eluting stent and bare-metal stent treatments in a real-world setting.
This study compared clinically driven target-lesion revascularization, target-vessel revascularization, and target-limb revascularization outcomes at 1 year between drug-eluting stent and bare-metal stent treatments in a real-world setting.
This study compared clinically...
09/30/2018
Journal of Invasive Cardiology
Original Contribution
08/15/2018

Shuangbo Liu, MD1;  Mali Worme, MD1;  Bobby Yanagawa, MD, PhD2;  Naresh Kumar, MD3;  Christopher E. Buller, MD1;  Asim N. Cheema, MD, PhD1;  Akshay Bagai, MD, MHS1

Shuangbo Liu, MD1;  Mali Worme, MD1; ...
To evaluate the efficacy of drug-coated balloon (DEB) for the treatment of drug-eluting stent in-stent restenosis.
To evaluate the efficacy of drug-coated balloon (DEB) for the treatment of drug-eluting stent in-stent restenosis.
To evaluate the efficacy of...
08/15/2018
Journal of Invasive Cardiology
Original Contribution
05/15/2018

Umberto Barbero, MD1,2;  Rahim Kanji, BSc, MBBS, MRCP2;  Enrico Cerrato, MD3;  Roberto Di Summa, MD4;  Federico Conrotto, MD4;  Hiroyoshi Kawamoto, MD5;  Giuseppe Biondi-Zoccai, MD, PhD6;  Sebastiano Gili, MD7;  Fabrizio Ugo, MD8;  Mario Iannaccone, MD8;  Marco Gagliardi, MD4;  Michele De Benedictis, MD1;  Baldassarre Doronzo, MD1;  Ferdinando Varbella, MD3;  Maurizio D‚ÄôAmico, MD4;  Claudio Moretti, MD4;  Antonio Colombo, MD9;  Javier Escaned, MD, PhD; Prof10;  Fabrizio D‚ÄôAscenzo, MD4

Umberto Barbero, MD1,2;  Rahim Kanji,...
An evaluation of the outcomes of patients undergoing PCI for unprotected left main coronary artery disease with different drug-eluting stent types.
An evaluation of the outcomes of patients undergoing PCI for unprotected left main coronary artery disease with different drug-eluting stent types.
An evaluation of the outcomes of...
05/15/2018
Journal of Invasive Cardiology
04/15/2018

Hui Wen Sim, MBBS1;  Rajiv Ananthakrishna, MBBS1;  Siew Pang Chan, PhD, MSIArb2;  Adrian F. Low, MBBS1,3;  Chi-Hang Lee, MBBS, MD1,3;  Mark Y. Chan, MBBS, MHS1,2;  Edgar L. Tay, MBBS1,3;  Poay Huan Loh, MBBS1;  Koo Hui Chan, MD1;  Huay Cheem Tan, MBBS1,2,3;  Joshua P. Loh, MBBS1,3

Hui Wen Sim, MBBS1;  Rajiv Ananthakri...
An evaluation of the 1-year clinical outcomes of patients treated with 2.0 mm drug-coated balloon vs 2.0 mm drug-eluting stent implantation in small-caliber vessel de novo coronary artery disease.
An evaluation of the 1-year clinical outcomes of patients treated with 2.0 mm drug-coated balloon vs 2.0 mm drug-eluting stent implantation in small-caliber vessel de novo coronary artery disease.
An evaluation of the 1-year...
04/15/2018
Journal of Invasive Cardiology
Original Contribution
04/15/2018

Naotaka Okamoto, MD;  Hiroshi Ueda, MD;  Takahiro Yoshimura, MD;  Surbhi Chamaria, MD;  Samit Bhatheja, MD;  Yuliya Vengrenyuk, PhD;  Samaneh Rabiei, MD;  Yonandy Barrientos, BS;  Vishal Kapur, MD;  Nitin Barman, MD;  Joseph Sweeny, MD;  Usman Baber, MD;  Roxana Mehran, MD;  Samin K. Sharma, MD;  Annapoorna S. Kini, MD

Naotaka Okamoto, MD;  Hiroshi Ueda, M...
The aim of the study was to compare the acute outcomes of Absorb bioresorbable vascular scaffolds (BVS) and second-generation drug-eluting stent implantation in routine clinical practice. There is a paucity of data regarding BVS use in a...
The aim of the study was to compare the acute outcomes of Absorb bioresorbable vascular scaffolds (BVS) and second-generation drug-eluting stent implantation in routine clinical practice. There is a paucity of data regarding BVS use in a...
The aim of the study was to...
04/15/2018
Journal of Invasive Cardiology
Original Contribution
02/25/2018

Slayman Obeid, MD; Nooraldaem Yousif, MD; Andreas Schelldorfer, MD; Mohammady Shahin, MD; Lorenz Räber, MD; Baris Gencer, MD; François Mach, MD; Marco Roffi, MD; Christian M. Matter, MD; Stephan Windecker, MD; Thomas F. Lüscher, MD, FRCP

Slayman Obeid, MD; Nooraldaem Yousif,...
A group of 2899 patients with acute coronary syndromes was studied to compare the safety and efficacy of those with LMCA disease vs those without LMCA disease. The primary endpoints of independently adjudicated major adverse cardiovascular...
A group of 2899 patients with acute coronary syndromes was studied to compare the safety and efficacy of those with LMCA disease vs those without LMCA disease. The primary endpoints of independently adjudicated major adverse cardiovascular...
A group of 2899 patients with...
02/25/2018
Journal of Invasive Cardiology